DGFT Minutes
In force — no superseding record on file.
Government of India Ministry of Commerce and Industry Department of Commerce DIRECTORATE GENERAL OF FOREIGN TRADE
Minutes of the Norms Committee – 3 Meeting No. NC/3/MEET/Jul/202324/09 dated 28/07/2023 (Manual Case) under the Chairmanship of Shri Rajiv Kumar Soni, Jt. DGFT for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30.
Following members were present in the Meeting:
| S.N. | Name & Designation | Department |
|---|---|---|
| 1 | Shri D.N. Mathur, Technical | Consultant |
| In attendance | ||
| 1 | Shri T. Songzalian, Deputy DGFT | DGFT |
| 2 | Shri Uttam Dey Sarkar, ASO | DGFT |
- The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case.
Manual Cases for Personal Hearing held on 28/07/2023.
| Case No. | Case No. | A-02 | A-02 | A-02 | A-02 | A-02 | A-02 | A-02 | A-02 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MeetingNo. | NC/3/MEET/Jul/202324/9 | ||||||||||||
| Date | 28/07/2023 | ||||||||||||
| Firm’s Name | M/s Arch Pharmalabs Limited | ||||||||||||
| HQ F. No. | HQRNORMREVIW00006595/AM23/DES-III<br>(Earlier F.No. 01/82/050/001218/AM19/DES-III) | ||||||||||||
| RLA F. No. | 03/94/040/00142/AM19 | ||||||||||||
| . . | |||||||||||||
| <br> <br> | Advance<br>Authorization | 0310822704 dat | ed 30/07/20 | 18 | |||||||||
| No. and Date | |||||||||||||
| Subject | Request of M/s A<br>description of Ex<br>5)” | rch Pharma<br>port Produc | labs Limi<br>t “3a-Hy | ted for fixation of<br>droxy-7-keto-5b-c | adhoc norms with the<br>holan-24-oic acid (IP- | ||||||||
| Decision : | Decision : | The Committee c | onsidered th | e reques | t of firm for fixatio | n of ad-hoc norms and | <br>r | ||||||
| it was decided to ratify ad-hoc norms under Para 4.07 of HBP Vol. I as pe<br>details given below or as applied by the firm, whichever is less:- | |||||||||||||
| Export Product | Qty | Sl.<br> | Import Items | Qty | |||||||||
| No. | |||||||||||||
| 1. 65 kg. | |||||||||||||
| 3a-Hydroxy-7-keto-<br> | 1 kg | 1 | CHOLIC ACID | 1. 65 kg. | |||||||||
| 5b-cholan-24-oic<br> | |||||||||||||
| 2 | HYDRAZINE | 1.65 kg. | |||||||||||
| acid (IP-5)<br> | <br>HYDRATE | ||||||||||||
| [7-Ketolithocholic<br>acid(3α-Hydroxy-7-<br> | (80% SOLUTION) | ||||||||||||
| 3 | ACETONE | Not imported | |||||||||||
| oxo-5β-cholanic<br> <br> | |||||||||||||
| acid),<br>Minimum<br> | 4 | IEP OX 239 SPRAY<br> <br> | 0.033 kg. | ||||||||||
| 99.75%. |
|||(80% SOLUTION)|||| ||||||||||3|ACETONE||Not imported|| ||||||oxo-5β-cholanic<br> <br>||||||||| ||||||||||||||| ||||||acid),<br>Minimum<br>||||4|IEP OX 239 SPRAY<br> <br>||0.033 kg.|| ||||||99.75%. No single<br>related or unrelated<br>|||||DRIED<br>ENZYME<br>POWDER|||| ||||||||||5|IEP OX 152 SPRAY||0050 k|| |impurity should be<br>more than 0.05%]<br> <br> <br>DRIED<br>ENZYME<br>POWDER<br>. g.<br>6<br>IEP OX 243 SPRAY<br>DRIED<br>ENZYME<br>POWDER<br>0.040 kg.<br>7<br>B-NAD)B-<br>NICOTINAMIDE-<br>ADENINE<br>DINUCLEOTIDE<br>( COENZYME-1)<br>0.008 kg.<br>**Note:**Above norms are for regularization and closure purpose only. No fres<br>license will be issued on above said ad-hoc norms. <br>RA concerned may take further necessary action as per above decision of<br>NC.|||||impurity should be<br>more than 0.05%]|||||<br>DRIED<br>ENZYME<br>POWDER||. g.|| ||||||||||6|IEP OX 243 SPRAY<br>DRIED<br>ENZYME<br>POWDER||0.040 kg.|| ||||||||||7|B-NAD)B-||0.008 kg.|| |||||||||||NICOTINAMIDE<br>ADENINE<br>|-<br>||| |||||||||||DINUCLEOTID<br>( COENZYME-1|<br>)||| ||||||**Note:**Above<br>license will be is|norms are for<br>sued on abo||regulari<br>ve said a||zation and closure<br>d-hoc norms.|purpose only. No fres||h| ||||||||||||||| ||||||RA concerned may take further necessary action as per above decision of<br>NC.||||||||| |||||||||||||||
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 8024 --apply.